MCP简体中文Upgrade
Market/Categories/Business Specialist/ArteraAI Prostate Test

Independent product intelligence · Worldwide · 2026-05-01 → 2026-07-31

ArteraAI Prostate Testartera.ai

ArteraAI offers an AI-powered test for localized prostate cancer that predicts therapy benefit and provides prognostic information, enabling personalized treatment decisions.

Business Specialistartera.aiTracked since 2026-08-211 discovery source
1.3KBacklinks
617Referring domains
27Domain authority
+17.5%Referring domains · 90 days

Authority & distribution

How strong is ArteraAI Prostate Test’s web footprint?

Backlinks measure accumulated distribution; referring domains show how broadly that authority is spread. Both are observable on the open web, so both are published for every product here.

Backlinks

1.3KCurrent snapshot

Referring domains

617Current snapshot

Authority

27Domain authority · category median 22

90-day move

+17.5%Referring domains, last 90 days
At 27, ArteraAI Prostate Test sits above the 22 median for its category.

Trajectory · Pro

The counts above are the latest of 370 daily observations. The curve through them is on the full profile.

See the trajectoryOpen the full profile

Traffic & engagement

Where ArteraAI Prostate Test ranks

Measured · Pro

Measured for this product: global rank, country rank and category rank.

Unlock this profileOpen the full profile

AI referral visibility

Which AI assistants are already sending ArteraAI Prostate Test traffic?

Measured · Pro

Measured for this product: AI referral traffic, which assistants refer it and which pages those referrals land on.

Unlock this profileOpen the full profile

Product profile

What ArteraAI Prostate Test is selling.

Traffic makes more sense when you can connect it to the actual product promise.

“ArteraAI Prostate Test”

ArteraAI offers an AI-powered test for localized prostate cancer that predicts therapy benefit and provides prognostic information, enabling personalized treatment decisions.

Business SpecialistSeen 2026-08-21 → 2026-08-21Coverage tier C

What we have measured

4 of 8 signal groups are available for this product: identity, authority and backlinks, AI referrals, search demand.

Not measured for this domain: traffic and engagement, audience demographics, country distribution, acquisition mix. Those sections are left out of the page rather than filled with estimates.

Canonical website: https://artera.ai

Observed across 1 discovery source.

Research questions

What the evidence answers about ArteraAI Prostate Test.

Every answer is tied to a source we collected, and the questions with no evidence behind them are left unanswered rather than guessed.

What does the ArteraAI Prostate Test do and what problem does it solve?

The ArteraAI Prostate Test is an AI-powered diagnostic tool for localized and metastatic prostate cancer. It predicts therapy benefit and provides prognostic information to enable personalized treatment decisions, addressing the need for precision oncology.

Who is the ArteraAI Prostate Test for?

The test is designed for clinicians treating prostate cancer patients, particularly for those with non-metastatic and metastatic hormone-sensitive prostate cancer (mHSPC). It provides individual risk estimates to inform treatment planning.

What features or capabilities does the ArteraAI platform offer?

ArteraAI offers a multimodal artificial intelligence (MMAI) platform that analyzes digital pathology and clinical data. It provides actionable insights across multiple cancers and is validated in dozens of large, randomized phase III clinical trials.

Is the ArteraAI Prostate Test FDA approved?

Yes, the US FDA has granted De Novo marketing authorization for ArteraAI Prostate, a novel AI-powered risk-stratification tool for patients with non-metastatic prostate cancer.

What is ArteraAI?

ArteraAI is a company that develops a multimodal artificial intelligence (MMAI) platform for personalized precision medicine in cancer therapy, with a primary product being the ArteraAI Prostate Test.

5 of 6 research questions are answered for this product. The rest need source evidence we have not collected yet, so they are left unanswered rather than guessed.

Behind the lock

Unlock full ArteraAI Prostate Test intelligence.

  • Backlink trajectoryThe figures above are the latest observation. The daily curve behind them holds 370.
  • AI referral detailHow much traffic assistants send, which 2 of them do it, and the 2 pages they land on.
  • Search structure and ranking depthOrganic against paid, brand against non-brand, and how many keywords rank in the top three against the long tail — which is what decides whether the demand is portable or tied to the name.
  • The rest of the marketPage through every leaderboard 100 rows at a time, put any five products side by side, and query the whole dataset over API / MCP.

Worldwide estimates · Data period 2026-05-01 → 2026-07-31. Figures are measured estimates intended for market research. Signals we have not measured for this domain are omitted, never estimated; a measured zero is still reported as zero. How this was measured